top of page
A Wholly Owned Subsidiary of
KRTL Holding Group Inc
(OTCIQ: KRTL)
​
KRTL News
All Posts
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
Apr 9
KRTL Holding Group, Inc Commences Trading on Upstream Under KRTL
Apr 2
KRTL Holding Group, Inc Approved to Dual List on Upstream
Mar 25
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria QuÃmico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
Mar 24
KRTL Biotech Implements MasterControl QMS to Enhance Regulatory Compliance and Pharmaceutical Importation Readiness
Mar 3
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director
Feb 12
KRTL Holding Group Inc. Welcomes Dr. Marcelo Bascope as Chief International Science Director
Feb 12
KRTL Holding Group Inc. Appoints Philip Polito to Board of Directors as Chief Strategy Officer
Feb 12
KRTL Holding Group Expands in Bolivia: A Strategic Leap for Biopharmaceutical Innovation
Feb 5
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria QuÃmico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
Jan 22
KRTL Holding Group Inc. Announces FDA FEI and NDC Certification Achievements by Wholly Owned Subsidiary KRTL Biotech Inc.
Jan 15
KRTL Holding Group Inc. (OTC: KRTL) Announces Launch of New KRTL Biotech Website to Streamline Pharmaceutical Industry Solutions
Jan 8
KRTL Holding Group Inc. Announces KRTL Biotech Inc. Acquires 55% Majority Stake in Nutrivance Global to Enhance API Distribution and Real-World Data Capabilities
Jan 8
KRTL Holding Appoints David Orn to Board of Directors
Dec 19, 2024
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
Dec 5, 2024
A Milestone for KRTL Holding Group, Inc. (OTC: KRTL)
Nov 26, 2024
bottom of page
